Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone call and a bone scan catch silent bone disease before it breaks?

NCT ID NCT07848490

Diagnosis Sponsor: Universidade do Porto Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 30, 2026 · Last updated Oct 01, 2026 · Updated 1 time

Summary

Researchers in Portugal are studying whether primary care clinics can find more cases of osteoporosis, including bone weakness linked to chronic kidney disease. They plan to assess fracture risk by phone using a tool called FRAX in about 622 adults aged 40 to 90, then offer bone density scans to those at higher risk. The study measures how common these conditions are and where diagnosis and treatment fall short.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
fracture risk assessment and bone density scanning
What this could lead to
If the approach works, primary care clinics could routinely spot osteoporosis and kidney-related bone weakness earlier, before fractures happen.
What could go wrong
This is an observational pilot in one country's primary care network, so it cannot prove that screening prevents fractures. Phone interviews and scans may miss people or produce unclear results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 622 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population comprises adults aged 40 to 90 years registered at the Primary Healthcare Units of the ULS de Barcelos/Esposende

Ages

40 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 40 years and 90 years; * Registered at participating Primary Healthcare Unit; * Capable of providing informed consent. Exclusion Criteria: * Life expectancy \<12 months; * Severe cognitive/physical impairment; * Inability to undergo DXA.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease mineral and bone disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome osteoporosis renal osteodystrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease mineral and bone disorder Osteoporosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ULS de Barcelos/Esposende

    Barcelos, 4750-333, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.